The Importance of CXCR4 Expression in Tumor Stroma as a Potential Biomarker in Pancreatic Cancer

Expression of CXCR4 in specimens from 33 patients with PDAC was evaluated by immunohistochemistry techniques and matched with clinicopathological parameters, overall and disease-free survival rates.